Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 18,000 shares at $8.66 ($156K) on 2023-09-15, disclosed to the SEC on 2023-09-19.
Scheduled sale ($156k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-08-17 | $167K | — | Filing → |